Strongbridge Biopharma Plc is a biopharmaceutical company which focuses on the development, in-licensing, acquisition, and commercialization of various complementary products and product candidates that target rare diseases.
Stock Price Prediction
Update at 5:00pm EST
1.952 - 1.961
1.961 - 1.969
1.789 - 1.799
1.799 - 1.808
1.884 - 1.901
1.901 - 1.915
as of: 2020-04-09 3:32:41 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.SBBP has closed below upper band by 43.5%. Bollinger Bands are 55.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to SBBP's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
2019-11-07 Strongbridge Biopharma (NASDAQ:SBBP) Receives “Buy” Rating from HC Wainwright HC Wainwright reissued their buy rating on shares of Strongbridge Biopharma (NASDAQ:SBBP) in a research report released on Wednesday, AnalystRatings.com reports. They currently have a $18.00 target price on the biotechnology company’s stock. SBBP has been the topic of several other reports. Zacks Investment Research lowered shares of Strongbridge Biopharma from a buy rating to […]
2019-10-31 Strongbridge Biopharma (SBBP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Strongbridge Biopharma (SBBP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.